Peter H Whincup Selected Research

Mobility Limitation (Difficulty Walking)

1/2022	Oral health problems and risk of incident disability in two studies of older adults in the United Kingdom and the United States.
12/2019	Oral Health, Disability and Physical Function: Results From Studies of Older People in the United Kingdom and United States of America.
1/2016	Hearing impairment and incident disability and all-cause mortality in older British community-dwelling men.
10/2015	Physical Activity and Falls in Older Men: The Critical Role of Mobility Limitations.
12/2014	Associations between fibrin D-dimer, markers of inflammation, incident self-reported mobility limitation, and all-cause mortality in older men.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter H Whincup Research Topics

Disease

26	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 04/2002
22	Inflammation (Inflammations) 11/2021 - 03/2006
21	Coronary Disease (Coronary Heart Disease) 04/2014 - 11/2002
18	Myocardial Infarction 01/2022 - 12/2003
18	Stroke (Strokes) 09/2017 - 11/2002
16	Heart Failure 01/2021 - 07/2007
15	Insulin Resistance 01/2018 - 06/2005
12	Type 2 Diabetes Mellitus (MODY) 01/2019 - 12/2005
9	Obesity 01/2022 - 03/2003
6	Atrial Fibrillation 09/2018 - 03/2012
5	Mobility Limitation (Difficulty Walking) 01/2022 - 12/2014
5	Hypertension (High Blood Pressure) 01/2020 - 06/2005
5	Birth Weight (Birth Weights) 03/2015 - 05/2003
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2008 - 06/2005
4	Activated Protein C Resistance (APC Resistance) 01/2022 - 04/2002
3	Tooth Loss 01/2022 - 12/2019
3	Frailty 01/2022 - 01/2021
3	Neoplasms (Cancer) 12/2020 - 02/2004
3	Chronic Renal Insufficiency 11/2017 - 05/2013
3	Vascular Diseases (Vascular Disease) 09/2017 - 12/2004
3	Diabetes Mellitus 09/2014 - 03/2011
2	Venous Thromboembolism 01/2022 - 11/2002
2	Vitamin D Deficiency 01/2021 - 09/2014
2	Orthostatic Hypotension (Postural Hypotension) 01/2021 - 10/2020
2	Glaucoma 12/2020 - 07/2010
2	Body Weight (Weight, Body) 01/2015 - 12/2006
2	Atherosclerotic Plaque (Atheroma) 02/2013 - 07/2009
2	Abdominal Obesity 04/2010 - 06/2005
2	Overweight 11/2007 - 12/2006
1	Thromboembolism 01/2022
1	Syncope (Fainting) 01/2021
1	Ocular Hypertension (Glaucoma, Suspect) 12/2020
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 12/2020
1	Low Tension Glaucoma 12/2020
1	Vascular Calcification 10/2020
1	Chronic Disease (Chronic Diseases) 01/2019
1	Hyperuricemia 02/2018
1	Overnutrition 01/2018
1	Diabetic Angiopathies (Diabetic Angiopathy) 09/2017

Drug/Important Bio-Agent (IBA)

23	C-Reactive ProteinIBA 01/2022 - 07/2005
15	Interleukin-6 (Interleukin 6)IBA 01/2022 - 12/2006
13	von Willebrand FactorIBA 01/2022 - 11/2002
12	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 02/2011
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2004
12	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 06/2011
12	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 06/2008
10	fibrin fragment D (D-dimer)IBA 01/2022 - 11/2002
9	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 11/2002
9	LipidsIBA 01/2019 - 12/2004
8	Triglycerides (Triacylglycerol)IBA 01/2020 - 06/2005
8	Insulin (Novolin)FDA Link 01/2018 - 11/2006
8	LeptinIBA 01/2017 - 05/2007
8	CholesterolIBA 03/2015 - 05/2003
7	Troponin T (Troponin T1)IBA 01/2022 - 01/2016
7	FibrinIBA 01/2022 - 11/2002
6	Fibrinogen (Factor I)FDA Link 01/2022 - 11/2002
6	AdiponectinIBA 01/2015 - 08/2006
5	Hemostatics (Antihemorrhagics)IBA 01/2021 - 04/2002
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2016 - 01/2006
4	Factor VIII (Coagulation Factor VIII)IBA 01/2022 - 07/2005
4	Blood Glucose (Blood Sugar)IBA 01/2020 - 06/2005
4	HDL CholesterolIBA 01/2020 - 06/2005
4	Uric Acid (Urate)IBA 02/2018 - 09/2014
4	TransferasesIBA 08/2017 - 05/2008
4	Warfarin (Coumadin)FDA LinkGeneric 03/2017 - 12/2003
4	AntigensIBA 05/2008 - 11/2002
3	Factor VII (Proconvertin)IBA 01/2022 - 04/2002
3	Vitamin D FDA LinkGeneric 01/2021 - 09/2014
3	Retinaldehyde (Retinal)IBA 12/2020 - 08/2011
3	EnzymesIBA 08/2017 - 12/2005
3	AdipokinesIBA 01/2013 - 05/2007
3	CotinineIBA 05/2012 - 07/2004
2	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2022 - 03/2017
2	ORALIT (ORS)IBA 01/2021 - 12/2010
2	hydroxide ionIBA 01/2021 - 10/2020
2	Phosphates (Orthophosphate)IBA 10/2020 - 05/2013
2	MagnesiumIBA 09/2018 - 04/2008
2	Biological ProductsIBA 02/2018 - 03/2003
2	Antihypertensive Agents (Antihypertensives)IBA 02/2018 - 07/2010
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2018 - 03/2014
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 07/2013 - 03/2006
2	Interleukin-18 (Interleukin 18)IBA 02/2013 - 07/2011
2	Environmental Pollutants (Pollutants, Environmental)IBA 07/2009 - 03/2009
2	Particulate MatterIBA 07/2009 - 03/2009
2	CytokinesIBA 07/2009 - 04/2008
2	Indicators and Reagents (Reagents)IBA 11/2007 - 06/2005
1	AnticoagulantsIBA 01/2022
1	Natriuretic PeptidesIBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	vinyltriethoxysilane (VTES)IBA 01/2019
1	Conjugated Linoleic AcidsIBA 01/2018
1	CystatinsIBA 11/2017
1	CreatinineIBA 11/2017
1	Receptor for Advanced Glycation End ProductsIBA 09/2017
1	BilirubinIBA 08/2017
1	4- azido- 7- phenylpyrazolo- (1,5a)- 1,3,5- triazineIBA 03/2017

Therapy/Procedure

3	Activities of Daily Living (ADL) 01/2022 - 01/2016
3	Secondary Prevention 09/2007 - 12/2005
2	Polypharmacy 01/2022 - 11/2021
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 09/2017